Erasca, Inc. (ERAS) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of Erasca, Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERAS
Erasca, Inc.
$14.48HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
SRRK
Scholar Rock Holding Corporation
$43.51HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
Total return — ERAS vs SRRK
growth of $100 · dividends reinvested · last 5yERAS -15.5% (-3.3%/yr)SRRK +51.7% (+8.7%/yr)SRRK compounded faster over this window
ERAS SRRK
ERAS vs SRRK: by the numbers
- •SRRK is the larger company ($5.21B vs $5.02B market cap).
Metrics side by side
Valuation
| Metric | ERAS | SRRK |
|---|---|---|
| P/B ratio | 13.89 | 20.54 |
Profitability
| Metric | ERAS | SRRK |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -79.37% | -161.00% |
| ROIC | -38.03% | -90.04% |
Growth (annualized)
| Metric | ERAS | SRRK |
|---|---|---|
| Total return CAGR (5Y) | -8.34% | 8.20% |
Frequently asked
- How have ERAS and SRRK total returns compared?
- Over the past 5 years, ERAS delivered -8.34% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.